COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,300 Articles (22,772 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 1849: Articles 18481-18490  | Next

Identification of B.1.346 lineage of SARS-CoV-2 in Japan: Genomic evidence of re-entry of Clade 20C
Kodai, A., Takako, S., Toshiki, T., Yuka, I., Hirotsugu, I., Yoshifumi, U., Shunsuke, U., Jun, G., Natsuo, T., Yuriko, T., Junpei, K., Hiroyuki, N., Susumu, F., Shikou, S., Morio, N., Kazuhiro, U., Takahiko, M., Jun, I., Kenichiro, Y., Toshio, K., Shinji, M., Kazuhiro, A., Tamotsu, E., Haruhiko, S., Naoki, H., Masayuki, A., Yuko, K., Makoto, S., Kenjiro, K.
10.1101/2021.01.29.21250798 — Posted: 2021-02-01
Genetically predicted serum vitamin D and COVID-19: a Mendelian randomization study
Patchen, B. K., Clark, A. G., Gaddis, N. M., Hancock, D. B., Cassano, P. A.
10.1101/2021.01.29.21250759 — Posted: 2021-02-01
Under what circumstances could vaccination offset the harm from a more transmissible variant of SARS-COV-2 in NYC? Trade-offs regarding prioritization and speed of vaccination.
Kim, H.-Y., Bershteyn, A., McGillen, J., Braithwaite, R. S.
10.1101/2021.01.29.21250710 — Posted: 2021-02-01
Diagnostic accuracy of PanbioTM rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
Ngo Nsoga, M.-T., Kronig, I., Perez Rodriguez, F. J., Sattonnet-Roche, P., Da Silva, D., Helbling, J., Sacks, J. A., de Vos, M., Boehm, E., Gayet- Ageron, A., Berger, A., Jacquerioz-Bausch, F., Chappuis, F., Kaiser, L., Schibler, M., Renzoni, A., Eckerle, I.
10.1101/2021.01.30.21250314 — Posted: 2021-02-01
Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2
Saadat, S., Rikhtegaran-Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., Sajadi, M. M.
10.1101/2021.01.30.21250843 — Posted: 2021-02-01 Discussion: Onsite
Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology
Karaba, A. H., Zhou, W., Hsieh, L. L., Figueroa, A., Massaccesi, G., Rothman, R. E., Fenstermacher, K. Z., Sauer, L., Shaw-Saliba, K., Blair, P. W., Leung, S., Wesson, R., Alachkar, N., El-Diwany, R., Ji, H., Cox, A. L.
10.1101/2021.01.29.21250317 — Posted: 2021-02-01
Sensitive extraction-free SARS-CoV-2 RNA virus detection using a novel RNA preparation method
Guan, B., Frank, K. M., Maldonado, J. O., Beach, M., Pelayo, E., Warner, B. M., Hufnagel, R. B.
10.1101/2021.01.29.21250790 — Posted: 2021-02-01
Retinol Depletion in Severe COVID-19
Sarohan, A. R., Akelma, H., Arac, E., Aslan, O.
10.1101/2021.01.30.21250844 — Posted: 2021-02-01 Discussion: Onsite
MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19's complications
Astore, C. A., Zhou, H., Jacob, J., Skolnick, J.
10.1101/2021.01.29.21250712 — Posted: 2021-02-01
A mathematical model to estimate percentage secondary infections from margin of error of diagnostic sensitivity: Useful tool for regulatory agencies to assess the risk of propagation due to false negative outcome of diagnostics
Palavesam, A., Kumaragurubaran, K., R Parthiban, A. B., TMA, S., Chidambaram, B., Gopal, D. R.
10.1101/2021.01.29.21250804 — Posted: 2021-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).